SCHEMBL9918951

SCHEMBL9918951

C=CCOc1cc(N=C=O)ccc1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.49
TRPA1 O75762 1/20 0.49
MAPK1 P28482 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
HPGD P15428 5/20 0.36
ALDH1A1 P00352 4/20 0.36
KDM4E B2RXH2 2/20 0.36
MAPT P10636 1/20 0.36
TSHR P16473 3/20 0.35
GAA P10253 2/20 0.35
PTGS1 P23219 1/20 0.34
PTGS2 P35354 1/20 0.34
HSD17B10 Q99714 1/20 0.34
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA9 Q16790 1/20 0.34
ACHE P22303 1/20 0.34
PDE4B Q07343 2/20 0.33
PDE4A P27815 1/20 0.33
PDE4C Q08493 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9918953 0.88 CYP3A4 (0.45) CYP3A4TRPA1MAPK1TDP1HPGD
SCHEMBL10980256 0.84 CYP3A4 (0.42) CYP3A4TRPA1MAPK1TDP1HPGD
SCHEMBL9528156 0.82 MAPK1 (0.51) CYP3A4TRPA1MAPK1TDP1HPGD
SCHEMBL9918935 0.75 HPGD (0.35) MAPK1HPGDALDH1A1KDM4EMAPT
SCHEMBL12458569 0.75 CYP3A4 (0.54) CYP3A4TRPA1MAPK1TDP1HPGD
SCHEMBL2454654 0.74 CA12 (0.49) CYP3A4HPGDALDH1A1MAPTTSHR
SCHEMBL7816047 0.74 HPGD (0.51) TDP1HPGDALDH1A1MAPTTSHR
SCHEMBL9918952 0.73 HPGD (0.39) CYP3A4TRPA1MAPK1TDP1HPGD
SCHEMBL9918940 0.73 ALDH1A1 (0.49) CYP3A4TRPA1HPGDALDH1A1KDM4E
SCHEMBL9918941 0.73 ALDH1A1 (0.43) CYP3A4TRPA1MAPK1TDP1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9334236-B2 Lactam-based compounds with a urethane or urea functional group, and uses thereof ISP INVESTMENTS INC. (US) 2016-05-10 US disclosed
US-9334236-B2 Lactam-based compounds with a urethane or urea functional group, and uses thereof ISP INVESTMENTS INC. (US) 2016-05-10 US disclosed
US-20120149861-A1 LACTAM-BASED COMPOUNDS WITH A URETHANE OR UREA FUNCTIONAL GROUP, AND USES THEREOF ISP INVESTMENTS LLC 2012-06-14 US disclosed
US-20120149861-A1 LACTAM-BASED COMPOUNDS WITH A URETHANE OR UREA FUNCTIONAL GROUP, AND USES THEREOF ISP INVESTMENTS LLC 2012-06-14 US disclosed
WO-2011022457-A1 LACTAM-BASED COMPOUNDS WITH A URETHANE OR UREA FUNCTIONAL GROUP, AND USES THEREOF ISP INVESTMENTS INC. (US) 2011-02-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149861-A1 LACTAM-BASED COMPOUNDS WITH A URETHANE OR UREA FUNCTIONAL GROUP, AND USES THEREOF CUTA, PUF60, PAM CYP3A4 2144/4885TRPA1 718/4885MAPK1 4391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.